Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Omeros CorporationNASDAQ: OMER
Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Free cash flow declines year over year
Q1 FY2026 free cash flow of $14.51M (cash outflow) fell 59.6% year over year, behind the -33.7% change in trailing-twelve-month free cash flow. Sequentially, it fell 63.6% from the prior quarter. Over 3 fiscal years it compounded at +10.3% a year.
Context
- Free cash flow increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -59.6% toward the trailing-twelve-month pace of -33.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (116.16M) USD
- Year-over-year change
- +22.0%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (116.16M) | +22.0% |
| FY2024 | 2024-12-31 | (148.97M) | -300.5% |
| FY2023 | 2023-12-31 | 74.3M | +185.8% |
| FY2022 | 2022-12-31 | (86.6M) | +21.3% |
| FY2021 | 2021-12-31 | (110M) | — |
Free Cash Flow vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's LTM Mar 2026 free cash flow of $94.78M is the 6th largest of the 11 companies compared; the peer median is $125.19M.
- Its year-over-year change of -33.7% is the lowest of 10, against a peer median of +23.0%.
- Free cash flow amounts to 958.1% of revenue for OMER, versus a peer median of 198.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $511.87M | -20.8% | +21.7% | — | |
| LTM Jun 2026 | $475M | +38.9% | — | 406.0% | |
| LTM Jun 2026 | $234.05M | +25.8% | -12.3% | 428.7% | |
| LTM Jun 2026 | $208.29M | +47.9% | +94.1% | 198.4% | |
| LTM Mar 2026 | $178.69M | +19.0% | +11.2% | — | |
| LTM Mar 2026 | $94.78M | -33.7% | +10.3% | 958.1% | |
| LTM Mar 2026 | $71.69M | -1.0% | -2.9% | 45.6% | |
| LTM Mar 2026 | $35.14M | +23.0% | +6.5% | — | |
| LTM Mar 2026 | $26.96M | -19.5% | -14.1% | 5391.1% | |
| LTM Mar 2026 | $4.41M | +104.0% | — | 1.9% | |
| LTM Dec 2025 | $0 | — | — | 0.0% | |
| Peer median (excluding OMER) | $125.19M | +23.0% | +6.5% | 198.4% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (191.55M) | (182.03M) | (117.81M) | (156.82M) | (3.35M) |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 11.65M | 10.49M | 8.19M |
| Change in Working Capital | (14.11M) | (118.97M) | 247.42M | 29.74M | 33.72M |
| Accounts Receivables | (34.31M) | (175.07M) | 245.72M | 40.01M | 30.45M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 14.64M | (10.67M) | 0 | 0 | 0 |
| Other Working Capital | 5.57M | 66.76M | 1.7M | (10.27M) | 3.27M |
| Other Non-Cash Items | 94.54M | 213.56M | (67.46M) | (33.17M) | (155.62M) |
| Operating Cash Flow | (109.72M) | (86.48M) | 74.73M | (148.8M) | (116.09M) |
| Capital Expenditures | (277K) | (113K) | (426K) | (165K) | (65K) |
| Acquisitions (Net) | 125.99M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (32.01M) | (429.05M) | (1.02B) | (987.39M) | (185.31M) |
| Sales of Investments | 100M | 301.59M | 1.05B | 1.07B | 109.9M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 240M |
| Investing Cash Flow | 193.71M | (127.56M) | 27.45M | 82.22M | 164.52M |
| Debt Repayment | (1.82M) | 123.83M | (101.58M) | (41.34M) | (89.16M) |
| Common Stock Issued | 8.38M | 415K | 0 | 0 | 46.99M |
| Common Stock Repurchased | 0 | 0 | (4.65M) | (11.85M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (241K) | 0 | 150K | 116.07M | 0 |
| Financing Cash Flow | 6.32M | 124.25M | (106.08M) | 62.88M | (42.17M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 90.31M | (89.8M) | (3.9M) | (3.71M) | 6.26M |
| Free Cash Flow | (110M) | (86.6M) | 74.3M | (148.97M) | (116.16M) |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.